Dabigatran, marked by Bohringer Ingelheim under the name ‘Pradaxa,’ is a direct thrombin inhibitor. It is often prescribed for patients who have atrial fibrillation, a rapid, irregular heart rhythm that affects more than two million Americans. People who suffer from atrial fibrillation have an increased risk of blood clots. These can travel to the brain and cause a stroke. Pradaxa is ...